• Profile
Close

Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: A multicenter study from China

HPB Dec 08, 2021

Chen ZH, Zhang XP, Feng JK, et al. - In cases of hepatocellular carcinoma (HCC) with microvascular invasion (MVI), tumor recurrence after hepatectomy was shown to have unique features and recurrence patterns. Improved long-term survival outcomes were achieved by early detecting tumor recurrence and with repeat liver resection with curative intent.

  • This is an analysis of a multicenter database of patients with HCC and MVI who underwent resection; a total of 1,517 patients with median follow-up of 39.7 months were included.

  • Overall 928 patients suffered tumor recurrence; 49% within 6 months of hepatectomy and 60% only in the liver, and a slow increase in the incidence of intrahepatic only recurrence was evident with time after 6 months.

  • Worse survival outcomes were experienced by patients who had recurrence within 6 months of hepatectomy vs those who developed recurrence later.

  • Better prognosis was reported for those with intrahepatic only recurrence vs those with either extrahepatic only recurrence or those with intra- and extrahepatic recurrence.

  • Better results were obtained with repeat resection of recurrence with curative intent vs other treatment approaches.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay